Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleExploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06881511 - Phase 2Not yet taking people in ChinaFruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 55
- Run by
- Ruijin Hospital
See details and how to joinNCT06888037 - No phaseNot yet taking people in ChinaPrognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 600
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06889402 - Phase 1/2Not yet taking people in ChinaFruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 44
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06871527 - Phase 2/3Not yet taking people in ChinaTotal Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC
- Where
- Beijing
- Age
- 18 years and over
- People
- 474
- Run by
- YIN LI
See details and how to joinNCT06861777 - No phaseTaking peopleEnergy CT in Imaging and Diagnosis of Gastric Cancer
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 300
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT06869694 - Phase 1Taking peopleBC001 in Combination with Sintilimab and XELOX in the Treatment of HER-2 Negative Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma.
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 80
- Run by
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773312 - No phaseEnrolling by invitationA Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 536
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06863831 - Phase 1Not yet taking people in ChinaPostoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients
- Where
- Beijing, Nanjing
- Age
- 18 years to 75 years
- People
- 48
- Run by
- Peking University
See details and how to joinNCT06857786 - Phase 1Taking peoplePersonalized DC Vaccine for Postoperative Cancer
- Where
- Chengdu
- Age
- 18 years to 100 years
- People
- 80
- Run by
- Sichuan University
See details and how to joinNCT04147078 - Phase 1/2Taking peoplePhase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 51
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT05319639 - No phaseTaking peopleEffect of Premedication With Pronase on Mucosal Cleanliness During EGD
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 3,000
- Run by
- Changhai Hospital
See details and how to joinNCT06713421 - Phase 2Taking peopleFMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
- Where
- Changzhou
- Age
- 18 years to 80 years
- People
- 198
- Run by
- Changzhou No.2 People's Hospital
See details and how to joinNCT06405113 - No phaseTaking peopleNanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 76
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06830018 - No phaseTaking peopleChemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
- Where
- Anyang, Luoyang
- Age
- 18 years to 75 years
- People
- 196
- Run by
- The First Affiliated Hospital of Henan University of Science and Technology
See details and how to joinNCT02972372 - Phase 2Not yet taking people in ChinaNeoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer
- Where
- Hexi District
- Age
- 18 years to 75 years
- People
- 57
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06814158 - Phase 2Taking peoplePD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer
- Where
- Shenzhen
- Age
- 18 years to 79 years
- People
- 62
- Run by
- Wan He
See details and how to joinNCT05033392 - Phase 1/2Taking peoplePostoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
- Where
- Hefei
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT05937438 - No phaseTaking peopleEffectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
- Where
- Beijing
- Age
- 50 years to 69 years
- People
- 21,000
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT06306755 - No phaseTaking peopleInvestigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
- Where
- Suzhou
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Zhao Jun
See details and how to joinNCT06790797 - Phase 2Taking peopleClinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 40
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06791083 - Phase 2Taking peopleLow-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 45
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06791148 - Phase 2Taking peoplePD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer
- Where
- Beijing
- Age
- 18 years and over
- People
- 20
- Run by
- Peking University Third Hospital
See details and how to joinNCT06792162 - No phaseTaking peopleThe Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 600
- Run by
- Fudan University
See details and how to joinNCT06786169 - Phase 1/2Taking peopleA Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer
- Where
- Shenzhen
- Age
- 18 years and over
- People
- 52
- Run by
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
See details and how to joinNCT06776770